Import Statistics of Capsul under NCM Code 30 Which Brazil Imports from United States Of America
View import statistics of capsul under NCM Code 30, which Brazil imports from United States Of America. Study market price & market size of capsul along with market share of Brazilian companies importing capsul from United States Of America.
18 Shipments Records (Demo)
30 
United States Of America
United States Of America | Date | NCM Code | Product Description | Origin Country | Quantity | Value | Importer Name | Click to view 16 more columns 16 More Columns Available |
|---|---|---|---|---|---|---|---|
| Jan/2019 | 30064012 | 472000 - equia strong intro kit description: modified glass ionomer resin for restoration - containing packaging: 5 capsules equia strong fil (cor) a1 5 capsules equia strong fil (cor) 2, 5 capsules equia strong fil (cor) a3 5 capsules equia fo | United States of America | 120 | 5,294.16 | ***** | 16 More Columns Available along with Company Name and Other Details etc. |
| Jan/2019 | 30049049 | Tafamidis meglumine or 20mg 40mg 80mg or or placebo - case containing 480 gelatin capsules lot: 18-002799 -val. 30.09.2019 * search clinic eec: 79/2017 | United States of America | 3 | 50,541.60 | ***** | |
| Jan/2019 | 30049049 | Labeled acp-196 bottle containing 30x (acalabrutinib) 100mg capsules for protocol ace-ly-308 - vials containing 30 acp-196 capsules (acalabrutinib) 100mg ace-ly-308 batch protocol: l0602706 or w032729 - data valid: 30 / jun / 2019 - product | United States of America | 10 | 533.70 | ***** | |
| Jan/2019 | 30049049 | Enzalutamide (mdv3100) 40mg capsule fill 124-labeled clinical bottle, tg 1; prt: mdv3100-14 - enzalutamide 40mg combined in bottles with 124 capsules. lot: 18-001645 - date expiry: 31 / jan / 2021 - product for research clinic n doprotocolo: | United States of America | 150 | 13,267.50 | ***** | |
| Jan/2019 | 30049099 | Labeled bottle containing 30ct ensartinib (x396) 100 mg capsules protocol for cli-301-x396 - 30 vials containing 100 mg capsules x396 for oral - batch: p186296-0003l001.a1.a1.p186296-0007l001 / l0700431 , l0609187 - expiry date: 31-may-202 | United States of America | 9 | 2,835 | ***** | |
| Jan/2019 | 30049068 | Trade name: reyataz - presentation: 200 mg cap hard ct fr hdpe opc x 60 plas. reyataz 200 mg cap (1btlx60) govt br - active principle: atazanavir sulfate. 1, 320, 000 capsules atazanavir (reyataz) 200mg, packed in bottles containing 60 capsul | United States of America | 22,000 | 1,148,400 | ***** |
